AKT inhibitor

A compound represented by formula I or a pharmaceutically acceptable salt thereof,

• wherein
• R1 is selected from the group consisting of H and C1-C6 alkyl, wherein the C1-C6 alkyl is optionally substituted by halogen or OH;
• R2 and R3 are each independently selected from the group consisting of H, C1-C6 alkyl, and C3-C6 cycloalkyl;
• or
• R1 and R2, together with the atoms to which R1 and R2 are attached, form a 4-7 membered nitrogen-containing heterocyclic ring;
• m is 1 or 2, n is 0;
• R4 and R5 form ═O together;
• is selected from the group consisting of
• R6, R7, R8, and R9 are each independently selected from the group consisting of H and C1-C6 alkyl, wherein the C1-C6 alkyl is optionally substituted by halogen;
• R10 is H or C1-C6 alkyl, wherein the C1-C6 alkyl is optionally substituted by halogen, OH or CN;
• L is selected from the group consisting of
• and is optionally substituted by one or more R12;
• wherein a single wavy line is a position where L is connected to carbonyl, and a double wavy line is a position where L is connected to pyrimidine;
• and wherein R12 is C1-C6 alkyl;
• G is a 6-10 membered aryl optionally substituted by 1-5 R11;
• R11 is halogen;
• provided that neither R1 nor R2 is H if R1 and R2, together with the atoms to which R1 and R2 are attached, form a 4-7 membered nitrogen-containing heterocyclic ring;
• and
• when L is
• is not